This site is intended for healthcare professionals only
LoginRegister
Submit global regulatory status of Atezolizumab for IV, SC route: CDSCO Panel Tells Roche Products IndiaSubmit global regulatory status of Atezolizumab for IV, SC route: CDSCO Panel Tells Roche Products...
Novartis concludes acquisition of Tourmaline BioNovartis tender offer for MorphoSys AG commences
Serum institute dengue treatmentSII partners with Univercells to bring affordable personalized oncology to masses
RocheRoche gets CE Mark for companion diagnostic to identify patients with HER2-low metastatic breast...
Revise Phase III Trial Protocol for Roflumilast Cream: CDSCO Panel Tells Sun PharmaSun Pharma receives OAI status from USFDA for Dadra facility
AstraZeneca Gets SEC Nod to Update Lokelma Prescribing Information for Hyperkalemia TreatmentCDSCO Panel grants AstraZeneca's proposal for withdrawing specific Indications of Olaparib Tablets
Palamur Biosciences Faces USFDA Warning for Multiple GLP Compliance FailuresRoche gets USFDA Breakthrough Device Designation for blood test to support earlier Alzheimer's...
Sun Pharma unit Taro recalls over 17k units of antifungal medication in USGlenmark, Lupin and 1 other recall products in US over manufacturing issues
RocheRoche Diagnostics India launches point-of-care NT-proBNP test for screening diabetes patients at...
Dr Reddys Russia Arm Slapped Rs 2.45 Cr VAT PenaltyDr Reddys Labs rolls out drug-free migraine management device Nerivio in Germany
Bayer-Regeneron Aflibercept 8 mg recommended for EU approval for third retinal indicationBayer, Google Cloud to accelerate development of AI-powered healthcare applications for radiologist
Abbott India Hit With Rs 2.40 Cr GST Penalty Over Alleged ITC Disallowance, Plans AppealConduct Phase-III clinical trial: CDSCO Panel tells Abbott on Ademetionine for Injection 400mg
X